Sponsor Pipeline

Fenix Innovation Group Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
0
Recruiting
2
Phase 3
Active Trials by Phase
Phase 3
1
Phase 2/3
1
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07257939 NTI164 in Autism Spectrum Disorder Autism Not Yet Recruiting
Phase 2/3
NCT07257978 Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome RETT Syndrome With Proven MECP2 Mutation Not Yet Recruiting
Phase 1/2
NCT06621043 Assessing the Safety and Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08%… Rett Syndrome Active, Not Recruiting
NCT06621888 Investigating The Effects Of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC… PANS Pediatric Acute-Onset Neuropsychiatric Syndrome Active, Not Recruiting
Phase 1
NCT06713447 NTI164 Human PK Study Healthy Active, Not Recruiting
Get alerts when Fenix Innovation Group's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free